Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage.

J Gastroenterol Hepatol

Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.

Published: July 2009

Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly prescribed drugs worldwide, which attests to their efficacy as analgesic, antipyretic and anti-inflammatory agents as well as anticancer drugs. However, NSAID use also carries a risk of major gastroduodenal events, including symptomatic ulcers and their serious complications that can lead to fatal outcomes. The development of "coxibs" (selective cyclooxygenase-2 [COX-2] inhibitors) offered similar efficacy with reduced toxicity, but this promise of gastroduodenal safety has only partially been fulfilled, and is now dented with associated risks of cardiovascular or intestinal complications. Recent advances in basic science and biotechnology have given insights into molecular mechanisms of NSAID-induced gastroduodenal damage beyond COX-2 inhibition. The emergence of newer kinds of NSAIDs should alleviate gastroduodenal toxicity without compromising innate drug efficacy. In this review, novel strategies for avoiding NSAID-associated gastroduodenal damage will be described.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1746.2009.05929.xDOI Listing

Publication Analysis

Top Keywords

gastroduodenal damage
12
non-steroidal anti-inflammatory
8
gastroduodenal
6
rescue strategies
4
strategies non-steroidal
4
anti-inflammatory drug-induced
4
drug-induced gastroduodenal
4
damage non-steroidal
4
anti-inflammatory drugs
4
drugs nsaids
4

Similar Publications

Article Synopsis
  • - This study examines the gastrointestinal safety of diclofenac sodium when administered via a transdermal patch (DSSP) versus an oral tablet (DST) in patients with low back pain (LBP).
  • - Results showed that DSSP significantly reduced the incidence of gastroduodenal ulcers and erosions (26.7%) compared to DST (86.2%), demonstrating a -59.5% difference in risk.
  • - Additionally, no adverse events were reported with DSSP, while 20% of patients using DST experienced mild adverse effects, highlighting DSSP's safety advantage.
View Article and Find Full Text PDF

[Diagnosis and treatment of gastrointestinal bleeding after kidney transplantation].

Beijing Da Xue Xue Bao Yi Xue Ban

October 2024

Department of Urology, The First Affiliated Hospital of Anhui Medical University; Institute of Urology, Anhui Medical University; Anhui Province Key Laboratory of Urological and Andrological Diseases Research and Medical Transformation, Hefei 230022, China.

Objective: To analyze the clinical characteristics of acute and chronic gastrointestinal bleeding in patients with end-stage renal disease (ESRD) after kidney transplantation, to improve the understanding of the causes, diagnosis, treatment and prevention of this complication, and to improve the management of patients with gastrointestinal bleeding after kidney transplantation.

Methods: The clinical, imaging and pathological data of patients with gastrointestinal bleeding after kidney transplantation in the Department of Urology of The First Affiliated Hospital of Anhui Medical University from August, 2015 to December, 2020 were collected. The etiology, early clinical manifestations, abnormal laboratory tests and examinations, treatment procedures, late prevention and treatment measures and outcomes of gastrointestinal bleeding were retrospectively studied, and the relevant literature was summarized and reviewed.

View Article and Find Full Text PDF

Usefulness of Hem-o-lok® clips to ligate the gastroduodenal artery in pancreatoduodenectomy.

HPB (Oxford)

December 2024

Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan.

Article Synopsis
  • Post-pancreatectomy hemorrhage (PPH) can be a deadly complication after pancreatoduodenectomy, particularly when a pancreatic fistula leads to arterial bleeding from a pseudoaneurysm.
  • Researchers evaluated the effectiveness of using Hem-o-lok® clips to ligate the gastroduodenal artery (GDA) stump as a method to prevent PPH, comparing it to a traditional knot-tying technique in a study with 468 patients.
  • Results showed that the clipping method significantly reduced the incidence of PPH, with only 4 cases (6.9%) in the clipping group compared to 12 cases (16.4%) in the knot-tying group, indicating that Hem-o-lok® clips are a
View Article and Find Full Text PDF

Bacteria are ideal anticancer agents and carriers due to their unique capabilities that are convenient in genetic manipulation, tumor-specific targeting, and deep-tissue penetration. However, the specific molecular mechanisms of bacteria-mediated cancer therapy (BMCT) have not been clarified. In this study, we found that TLR4 signaling pathway is critical for Salmonella-mediated tumor targeting, tumor suppression, and liver and spleen protection.

View Article and Find Full Text PDF

Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.

Indian Heart J

September 2024

Medical Affairs, Alkem Laboratories Ltd, ALKEM HOUSE, "Devashish", Adjacent to Matulya Centre, Senapati Bapat Marg, Lower Parel, Mumbai, 400 013, India. Electronic address:

Objective: To compare the efficacy and safety of a fixed-dose combination of aspirin and pantoprazole with that of aspirin alone for the prevention of gastro duodenal mucosal damage in patients taking aspirin for secondary prevention of cardiovascular disease or cerebrovascular disease.

Methods: This was a comparative, double-blind, double-dummy, randomized, multicenter, phase III study conducted in patients taking aspirin ≤150 mg daily for ≥3 to ≤6 months and expected to require daily aspirin therapy for at least 6 months for the secondary prevention of cardiovascular disease or cerebrovascular disease.

Results: A total of 240 patients were randomized to receive either a fixed-dose combination of aspirin 150 mg and pantoprazole 20 mg or aspirin 150 mg alone in a 2:1 ratio.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!